Hannah Brendan

SEC source: 0000912282-26-000119 · form4.xml · derivative · entry 1

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,000

Underlying: Common Shares · 365,000 shares

Expires 2036-01-23

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting with 1/48th vesting on the date of grant and the remaining options vesting on the 1st day of each subsequent month, such that the total number of shares shall be fully vested on December 1, 2029.

SEC source: 0000912282-25-001370 · form4.xml · derivative · entry 4

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,720

Underlying: Common Shares · 25,280 shares

Expires 2033-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date.

SEC source: 0000912282-25-001370 · form4.xml · derivative · entry 3

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,168

Underlying: Common Shares · 2,271 shares

Expires 2032-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.

SEC source: 0000912282-25-001370 · form4.xml · nonDerivative · entry 2

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 361,827

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000912282-25-001370 · form4.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000912282-25-000697 · form4.xml · derivative · entry 2

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,736

Underlying: Common Shares · 37,736 shares

Expires 2030-06-18

SEC source: 0000912282-25-000697 · form4.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · CBO, COO & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,276

SEC source: 0001415889-25-003613 · form4-02112025_100238.xml · derivative · entry 1

Hannah Brendan · CIK 0001929422 · CBO, COO and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2035-01-27

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2025, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 6

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,540

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 5

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,975

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 4

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,975

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 3

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,695

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 2

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,271

SEC source: 0001415889-24-021869 · form4-08212024_100803.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 259,771

SEC source: 0001415889-24-015533 · form4-06052024_060635.xml · derivative · entry 2

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,439

Underlying: Common Stock · 56,061 shares

Expires 2032-03-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.

SEC source: 0001415889-24-015533 · form4-06052024_060635.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,616

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-002379 · form4-02022024_100258.xml · derivative · entry 1

Hannah Brendan · CIK 0001929422 · CHIEF BUSINESS OFFICER AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2024, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.

SEC source: 0001209191-23-053695 · doc4.xml · derivative · entry 1

Hannah Brendan · CIK 0001929422 · Chief Business Officer and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2033-10-23

F1 · derivative.exercise_date: 1/48th of the total number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the vesting commencement date of October 23, 2023.

SEC source: 0001209191-23-045234 · doc4.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,555

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001209191-23-006394 · doc4.xml · derivative · entry 1

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2033-01-31

F1 · derivative.exercise_date: The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.

SEC source: 0001209191-22-031498 · doc4.xml · derivative · entry 3

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,656

Underlying: Common Stock · 353,656 shares

Expires 2032-05-22

F2 · derivative.exercise_date: The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.

SEC source: 0001209191-22-031498 · doc4.xml · derivative · entry 2

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,500

Underlying: Common Stock · 103,500 shares

Expires 2032-03-27

F3 · price: Received in the Merger in exchange for an employee stock option to acquire 1,136,600 shares of Novosteo common stock for $0.05 per share.

F2 · derivative.exercise_date: The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.

SEC source: 0001209191-22-031498 · doc4.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,224

F1 · price: On March 19, 2022, the Issuer completed acquisition (the "Merger") of Novosteo Inc. ("Novosteo"), pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, (the "Merger Agreement"), by and among the Issuer, Quince Merger Sub I, Inc., a wholly owned subsidiary of the Issuer, Quince Merger Sub II, LLC, a wholly owned subsidiary of the Issuer, Novosteo, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative. Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by the Reporting Person in Novosteo were automatically cancelled and converted into the right to receive shares of common stock of the Issuer.

SEC source: 0001209191-22-032672 · doc4a.xml · nonDerivative · entry 1

Hannah Brendan · CIK 0001929422 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,793

F1 · shares: The shares vest monthly, subject to continued service.

F2 · price: On March 19, 2022, the Issuer completed acquisition (the "Merger") of Novosteo Inc. ("Novosteo"), pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, (the "Merger Agreement"), by and among the Issuer, Quince Merger Sub I, Inc., a wholly owned subsidiary of the Issuer, Quince Merger Sub II, LLC, a wholly owned subsidiary of the Issuer, Novosteo, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative. Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by the Reporting Person in Novosteo were automatically cancelled and converted into the right to receive shares of common stock of the Issuer.